CClinicalTrials.gg
Sign In
CompletedNCT06455657Updated Jun 4, 2026

Breast Cancer Education to Prisoner Women

An interventional study of breast cancer education in Breast Cancer, sponsored by Hitit University. Completed at 3 sites in Turkey (Türkiye). Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-06-04.

Sponsored by Hitit University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

this study evaluated the impact of breast cancer education on knowledge and awareness among incarcerated women using a quasi-experimental design.

Read the detailed description

this study evaluated the impact of breast cancer education on knowledge and awareness among incarcerated women using a quasi-experimental design.

02

Conditions studied

  • Breast Cancer

Browse trials for

03

In context

Breast Neoplasms

12,543 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's enrollment of 40 is below the median of 72 across 9,302 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Hitit University is the lead sponsor of 79 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Volunteering to participate in the study,
  • Being between the ages of 18-65,
  • No history of breast cancer,
  • To know Turkish.

Exclusion criteria

Exclusion Criteria:

  • Those who do not agree to participate in the study,
  • Having a history of breast cancer,
  • Those who do not speak Turkish
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Prisoner women receiving breast cancer training

    Questionnaires and scales will be administered to the participants as a pre-test. Breast cancer education will be provided in groups and their feedback will be received. Reminder training will be repeated 1 month after the training. The survey and scales will be administered to the participants as a posttest 1 month after the second training.

    Other: breast cancer education

Interventions

  • Otherbreast cancer education

    Questionnaires and scales will be administered to the participants as a pre-test. Breast cancer education will be provided in groups and their feedback will be received. Reminder training will be repeated 1 month after the training. The survey and scales will be administered to the participants as a posttest 1 month after the second training.

06

What researchers measure

Primary outcomes

  1. Breast Cancer Awareness Scale

    The scale is used to measure breast cancer awareness by assessing knowledge of symptoms, appropriate age-related risk, and breast self-examination practices. Higher total scores reflect higher awareness levels.

    Time frame: first-2. months

Secondary outcomes

  1. Comprehensive Breast Cancer Knowledge Test

    The scale is used to evaluate breast cancer knowledge and perceptions of treatability through true-false statements, with higher scores reflecting greater knowledge levels.

    Time frame: first- 2. months

07

Study locations

3 sites
  • Hitit university
    Çorum, Turkey (Türkiye)
  • Fatma Yıldırım
    Çorum, Çorum 19600, Turkey (Türkiye)
  • L type prison
    Çorum, Çorum 19600, Turkey (Türkiye)
08

References and documents

Publications

  • Black E, Richmond R. Improving early detection of breast cancer in sub-Saharan Africa: why mammography may not be the way forward. Global Health. 2019 Jan 8;15(1):3. doi: 10.1186/s12992-018-0446-6. PubMed 30621753 ↗
  • Choi JS, Park M. Factors predicting young women's willingness to conduct vulvar self-examinations in Korea. Health Care Women Int. 2019 Jun;40(6):653-664. doi: 10.1080/07399332.2018.1531003. Epub 2018 Dec 14. PubMed 30550371 ↗
  • Jemal A, Bray F, Forman D, O'Brien M, Ferlay J, Center M, Parkin DM. Cancer burden in Africa and opportunities for prevention. Cancer. 2012 Sep 15;118(18):4372-84. doi: 10.1002/cncr.27410. Epub 2012 Jan 17. PubMed 22252462 ↗
  • Mohamed, A. O. A., Nori, M. M. M., & Altamih, R. A. A. (2021). The Effectiveness of Breast Cancer Health Education Campaign and Breast Self-Examination Training among Female Detainees, Khartoum City-Sudan. Journal of Environmental Science and Public Health, 5(2), 296-310
  • Saadeldin A. Idris, Aamir A. Hamza, Mohamed M. Hafiz, Mohammed Eltayeb A. Ali, Gamal E. H. A., El Shallaly Knowledge, attitude and practice of breast self examination among final years female medical students in Sudan. Int J Public Health Res 2013;1:6-10
  • American Cancer Society. Breast Cancer Information & Overview. 2023. Available from: https://www.cancer.org/cancer/types/breast-cancer.html
  • Baş, S., Ursavaş, F.(2022). Meme Kanseri Farkındalık Ölçeğinin Geçerlilik ve Güvenilirliği, Çankırı Karatekin Üniversitesi Sağlık Bilimleri Enstitüsü Hemşirelik Anabilim Dalı, Yüksek Lisans Tezi

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06455657
Lead sponsor
Hitit University
Responsible party
Fatma Yildirim (Principal Investigator, Hitit University) — Principal investigator
First posted
Jun 12, 2024
Start date
May 24, 2024
Primary completion
Aug 15, 2024
Completion
Aug 15, 2024
Last update
Jun 4, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Breast Neoplasms→

Other studies from this sponsor

Hitit University

Start the discussion